GetTopicDetailResponse(id=58b31231310e, topicName=代償期乙肝肝硬化, introduction=, content=PEG IFNα-2b 代償期乙肝肝硬化, image=null, comments=0, allHits=408, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Jan 07 12:32:18 CST 2025, time=2025-01-07, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=500264, tagList=[TagDto(tagId=500264, tagName=代償期乙肝肝硬化)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2261566, encodeId=df54226156609, content=<a href='/topic/show?id=bdfe1164500a' target=_blank style='color:#2F92EE;'>#APASL 2025#</a> <a href='/topic/show?id=58b31231310e' target=_blank style='color:#2F92EE;'>#代償期乙肝肝硬化#</a>, objectTitle=APASL2025丨CHESS 2306隊(duì)列研究：代償期乙肝肝硬化患者接受基于聚乙二醇干擾素α-2b的治療可顯著降低肝臟硬度值, objectType=article, longId=870179, objectId=7a2c8e0179b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240708/1720420381665_92910.jpg, objectUrl=/article/show_article.do?id=7a2c8e0179b6, replyNumber=0, likeNumber=44, createdTime=2025-04-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2c8e0179b6, moduleTitle=APASL2025丨CHESS 2306隊(duì)列研究：代償期乙肝肝硬化患者接受基于聚乙二醇干擾素α-2b的治療可顯著降低肝臟硬度值, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7a2c8e0179b6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2246935, encodeId=7ac722469354e, content=<a href='/topic/show?id=16fd1164520e' target=_blank style='color:#2F92EE;'>#PEG IFNα-2b#</a> <a href='/topic/show?id=58b31231310e' target=_blank style='color:#2F92EE;'>#代償期乙肝肝硬化#</a>, objectTitle=【期刊導(dǎo)讀】再次證實(shí)：聚乙二醇干擾素α-2b治療代償期乙肝肝硬化的安全性良好, objectType=article, longId=857319, objectId=d1bd85e3196c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=d1bd85e3196c, replyNumber=0, likeNumber=54, createdTime=2025-01-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=d1bd85e3196c, moduleTitle=【期刊導(dǎo)讀】再次證實(shí)：聚乙二醇干擾素α-2b治療代償期乙肝肝硬化的安全性良好, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d1bd85e3196c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-01-07發(fā)表于陜西省
